Dietary Flavones as Dual Inhibitors of DNA Methyltransferases and Histone Methyltransferases
Open Access
- 22 September 2016
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 11 (9) , e0162956
Abstract
Methylation of DNA and histone proteins are mutually involved in the epigenetic regulation of gene expression mediated by DNA methyltransferases (DNMTs) and histone methyltransferases (HMTs). DNMTs methylate cytosine residues within gene promoters, whereas HMTs catalyze the transfer of methyl groups to lysine and arginine residues of histone proteins, thus causing chromatin condensation and transcriptional repression, which play an important role in the pathogenesis of cancer. The potential reversibility of epigenetic alterations has encouraged the development of dual pharmacologic inhibitors of DNA and histone methylation as anticancer therapeutics. Dietary flavones can affect epigenetic modifications that accumulate over time and have shown anticancer properties, which are undefined. Through DNA binding and in silico protein-ligand docking studies with plant flavones viz. Apigenin, Chrysin and Luteolin, the effect of flavones on DNA and histone methylation was assessed. Spectroscopic analysis of flavones with calf-thymus DNA revealed intercalation as the dominant binding mode, with specific binding to a GC-rich sequence in the DNA duplex. A virtual screening approach using a model of the catalytic site of DNMT and EZH2 demonstrated that plant flavones are tethered at both ends inside the catalytic pocket of DNMT and EZH2 by means of hydrogen bonding. Epigenetic studies performed with flavones exhibited a decrease in DNMT enzyme activity and a reversal of the hypermethylation of cytosine bases in the DNA and prevented cytosine methylation in the GC-rich promoter sequence incubated with the M.SssI enzyme. Furthermore, a marked decrease in HMT activity and a decrease in EZH2 protein expression and trimethylation of H3K27 were noted in histones isolated from cancer cells treated with plant flavones. Our results suggest that dietary flavones can alter DNMT and HMT activities and the methylation of DNA and histone proteins that regulate epigenetic modifications, thus providing a significant anticancer effect by altering epigenetic processes involved in the development of cancer.Keywords
Funding Information
- U.S. Department of Veterans Affairs (1I01BX002494)
- National Cancer Institute (R01CA108512)
- National Cancer Institute (R21CA193080)
- National Cancer Institute (R03CA186179)
- Congressionally Directed Medical Research Programs (W81XWH-15-1-0558)
This publication has 55 references indexed in Scilit:
- The role of DNA methylation in directing the functional organization of the cancer epigenomeGenome Research, 2015
- The Interaction between Epigenetics, Nutrition and the Development of CancerNutrients, 2015
- Identification of coexistence of DNA methylation and H3K27me3 specifically in cancer cells as a promising target for epigenetic therapyCarcinogenesis, 2014
- Epigenetic regulation in cancer progressionCell & Bioscience, 2014
- EZH2: Not EZHY (Easy) to DealMolecular Cancer Research, 2014
- Canonical and non-canonical roles of the histone methyltransferase EZH2 in mammary development and cancerMolecular and Cellular Endocrinology, 2014
- Molecular Modeling Evaluation of Non‐Steroidal Aromatase Inhibitors†Chemical Biology & Drug Design, 2012
- Flavonoids Health Benefits and Their Molecular MechanismMini-Reviews in Medicinal Chemistry, 2011
- DNA Adducts with Antioxidant Flavonoids: Morin, Apigenin, and NaringinDNA and Cell Biology, 2008
- The Polycomb group protein EZH2 directly controls DNA methylationNature, 2005